Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops
- PMID: 9885752
Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops
Abstract
Background: Two ophthalmic solutions of 0.3% ciprofloxacin eyedrops are available in Turkey: Ciloxan and Siprogut. The objective of this study was to compare the concentrations of drug produced by the two products in the aqueous humour and vitreous humour after local administration.
Methods: Twenty-one patients undergoing primary vitreoretinal surgery received either Ciloxan (10 patients) or Siprogut (11 patients). Six hours before surgery, two drops of solution were instilled onto the operative eye. Drops were then instilled every 30 minutes for the first 3 hours and then hourly for the next 3 hours. Aqueous and vitreous samples were collected 30 minutes after administration of the last dose and were assayed for ciprofloxacin concentration by means of high-performance liquid chromatography with fluorometric detection.
Results: The mean aqueous humour concentrations of Ciloxan and Siprogut were 0.36 (standard error of the mean [SEM] 0.09) microgram/mL and 0.44 (SEM 0.17) microgram/mL respectively. The corresponding vitreous humour concentrations were 0.21 (SEM 0.05) microgram/mL and 0.22 (SEM 0.06) microgram/mL. Neither of these differences was statistically significant. The aqueous and vitreous levels of both products exceeded the minimum inhibitory concentrations for certain bacterial species that frequently cause intraocular infections.
Interpretation: Our results show that the ocular bioavailability of Ciloxan and Siprogut after local administration is equivalent. Penetration of ciprofloxacin into the vitreous humour seems to be poorer than that into the aqueous humour.
Similar articles
-
Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration.Eye (Lond). 1999 Aug;13 ( Pt 4):555-8. doi: 10.1038/eye.1999.137. Eye (Lond). 1999. PMID: 10692930 Clinical Trial.
-
Comparison of subretinal fluid levels of two 0.3% ciprofloxacin-containing eye drops.Clin Exp Ophthalmol. 2001 Feb;29(1):30-2. doi: 10.1046/j.1442-9071.2001.00362.x. Clin Exp Ophthalmol. 2001. PMID: 11272782
-
Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects.Eye (Lond). 1999 Oct;13 ( Pt 5):656-9. doi: 10.1038/eye.1999.178. Eye (Lond). 1999. PMID: 10696321 Clinical Trial.
-
Use of quinolones for treatment of ear and eye infections.Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):296-303. doi: 10.1007/BF01967003. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1864290 Review.
-
Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery.Curr Eye Res. 2023 Feb;48(2):208-218. doi: 10.1080/02713683.2022.2119254. Epub 2022 Nov 28. Curr Eye Res. 2023. PMID: 36036478 Review.
Cited by
-
Lens concentration of ofloxacin and lomefloxacin in an experimental endophthalmitis model.Curr Ther Res Clin Exp. 2007 May;68(3):184-90. doi: 10.1016/j.curtheres.2007.06.003. Curr Ther Res Clin Exp. 2007. PMID: 24683209 Free PMC article.
-
Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans.Br J Ophthalmol. 2000 Sep;84(9):1061-3. doi: 10.1136/bjo.84.9.1061. Br J Ophthalmol. 2000. PMID: 10966968 Free PMC article. Clinical Trial.
-
Comparative review of topical ophthalmic antibacterial preparations.Drugs. 2001;61(2):175-85. doi: 10.2165/00003495-200161020-00003. Drugs. 2001. PMID: 11270936 Review.
-
MRI in ocular drug delivery.NMR Biomed. 2008 Nov;21(9):941-56. doi: 10.1002/nbm.1230. NMR Biomed. 2008. PMID: 18186077 Free PMC article. Review.